ACKERMAN JOEL 4
4 · CHAMPIONS ONCOLOGY, INC. · Filed Nov 18, 2024
Insider Transaction Report
Form 4
ACKERMAN JOEL
DirectorChief Executive Officer
Transactions
- Award
Option to purchase Common Stock
2024-11-12$4.64/sh+43,190$200,402→ 43,190 totalExercise: $4.64Exp: 2034-11-12→ Common Stock (43,190 underlying)
Footnotes (1)
- [F1]The options vest and are exercisable over a twelve month period, with vesting to occur on November 12, 2024, February 12, 2025, May 12, 2025 and August 12, 2025, respectively.